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Thromboembolic disorders may be divided into those of arterial and 
venous origins, which encompass distinctive pathogenetic trajectories. 
Ischaemic heart disease and ischaemic stroke embody the majority of 
arterial thromboses, while deep-vein thrombosis and pulmonary 
embolism comprise the majority of venous thromboembolic events.
The subject of discussion is acquired thrombotic disorders, the 
second of a 2-part series in CME. Inherited thrombophilia is 
discussed in part 1 (previous issue).[1]
The content elaborates on pathophysiological and diagnostic facets 
of thrombotic disorders likely to be encountered in clinical practice. 
As regards current management practice, readers are referred to the 
South African prophylactic and therapeutic guideline.[2] 
Causes of acquired thrombophilia are numerous and varied, 
precluding a comprehensive discussion of all listed thrombotic 
disorders. Common clinical scenarios, however, are covered in greater 
detail. Thrombosis may occur as a consequence or complication 
of a wide variety of disease states, such as diabetes, hypertension, 
thrombotic thrombocytopenic purpura and liver transplantation. 
These events are influenced by a multitude of factors with varied 
aetiologies that merit discussion on discipline-specific platforms, 
and are therefore not within the scope of this CME. The scope of 
discussion is limited to clinical entities associated with a marked 
increase in the risk of thrombosis. We conclude with a guide to 
diagnosis and further investigation of suspected thromboembolic 
disease.
Fig. 1, which also appeared in part 1,[1] has been duplicated in the 
article in this issue for ease of reference.
The authors are indeed grateful for the opportunity to discuss this 
important and dynamic segment of coagulation disorders.
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